Formylpyrrole-based heterocycles for nucleic acid attachment to supports

US9475831B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9475831-B2
Application numberUS-201615002258-A
CountryUS
Kind codeB2
Filing dateJan 20, 2016
Priority dateJan 19, 2011
Publication dateOct 25, 2016
Grant dateOct 25, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A compound has Formula I: A, B, C, D, W, X, Y, and Z are independently selected from hydrogen, optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 6 alkoxy, aryl, aldehyde, protected aldehyde, CH, N, O, S, null, and bond; Q is selected from aldehyde, protected aldehyde, and null, at least one of A, B, C, D, W, X, Y, Z, or Q is an aldehyde or protected aldehyde; the bonds between each of A-B, B-C, C-D, W-X, X-Y, and Y-Z are selected from single bond, double bond, triple bond, and no bond; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; one or more methylene unit (CH 2 ) of the C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl(C═O), and NH; and R 1 and R 2 are independently selected from —NR 3 R 4 , halogen, C 1 -C 8 alkoxy, aralkoxy, alkenyloxy, alkynyloxy, and OCH 2 CH 2 CN; R 3 and R 4 are independently a C 1 -C 4 , straight chain or branched alkyl group.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of Formula III: wherein, W, X, Y, and Z comprise a fused ring system selected from the group consisting of a furan, a thiophene, a pyridazine, a pyrazine, and a pyrimidine; A is selected from the group consisting of aryl, hydrogen, hydroxyl, hydroxyalkyl, a C 1 -C 4 straight chain or branched alkyl and alkoxy; Q is an aldehyde or protected aldehyde; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; wherein one or more methylene unit (CH 2 ) unit of said C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl (C═O), and NH; and R 1 and R 2 are independently selected from the group consisting of —NR 3 R 4 , halogen, C 1 -C 8 alkoxy, aralkoxy, alkenyloxy, alkynyloxy, and OCH 2 CH 2 CN; wherein R 3 and R 4 are independently a C 1 -C 4 , straight chain or branched alkyl group. 2. The compound of claim 1 , wherein the protected aldehyde is selected from the group consisting of an acetal, an aminal, a dithioacetal, a protected hemiaminal, an alkene, and a protected hemithioacetal. 3. The compound of claim 1 , wherein A is hydrogen or methyl, Q is a protected aldehyde, R 1 is N-iPr 2 , and R 2 is OCH 2 CH 2 CN. 4. The compound of claim 1 , wherein A is a hydroxyl, alkoxy or hydroxyalkyl, Q is a protected aldehyde, R 1 is N-iPr 2 , and R 2 is OCH 2 CH 2 CN. 5. A compound of Formula IV: wherein, W, X, Y, and Z comprise a fused ring system selected from the group consisting of a furan, a thiophene, a pyridazine, a pyrazine, and a pyrimidine; A is selected from the group consisting of aryl, hydrogen, hydroxyl, alkoxy hydroxyalkyl, and a C 1 -C 4 straight chain or branched alkyl; Q is an aldehyde or protected aldehyde; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; wherein one or more methylene unit (CH 2 ) of said C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl (C═O), and NH; and Nu is a nucleic acid. 6. The compound of claim 5 , wherein the protected aldehyde is selected from the group consisting of an acetal, an aminal, a dithioacetal, a protected hemiaminal, an alkene, and a protected hemithioacetal. 7. The compound of claim 5 , wherein A is hydrogen or methyl, Q is a protected aldehyde, Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 8. The compound of claim 5 , wherein A is hydrogen or methyl, Q is a protected aldehyde, Nu is selected from the group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 9. The compound of claim 5 , wherein A is hydroxyl, alkoxy, or hydroxyalkyl, Q is a protected aldehyde, and Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 10. The compound of claim 5 , wherein A is hydroxyl, alkoxy or hydroxyalkyl, Q is a protected aldehyde, and Nu is selected from a group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 11. A support-bound nucleic acid of Formula V: wherein, W, X, Y, and Z comprise a fused ring system selected from the group consisting of a furan, a thiophene, a pyridazine, a pyrazine, and a pyrimidine; A is selected from the group consisting of aryl, hydrogen, hydroxyl, alkoxy hydroxyalkyl, and a C 1 -C 4 straight chain or branched alkyl; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; wherein one or more methylene unit (CH 2 ) of said C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl (C═O), and NH; Nu is a nucleic acid; Su is a support material; and B is a single or double bond, such that when B is a single bond, R is hydrogen and when B is a double bond R is null. 12. The support-bound nucleic acid of claim 11 , wherein A is hydrogen or methyl, Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 13. The support-bound nucleic acid of claim 11 , wherein A is hydrogen or methyl, Nu is selected from the group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 14. The support-bound nucleic acid of claim 11 , wherein A is hydroxyl, alkoxy, or hydroxyalkyl, and Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 15. The support-bound nucleic acid of claim 11 , wherein A is hydroxyl, alkoxy or hydroxyalkyl, and Nu is selected from the group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 16. The support-bound nucleic acid of claim 11 , wherein the support material is selected from the group consisting of a silica bead, CPG glass, a polymer bead, a microfluidic cell, and a 96 well plate. 17. The support-bound nucleic acid of claim 16 , wherein said polymer bead comprises a polymer selected from the group consisting of polystyrene, agarose, polyacrylate, and polyacrylamide. 18. A method of immobilizing a nucleic acid comprising forming a Schiff-base product by reaction of a compound of Formula IV: wherein, W, X, Y, and Z comprise a fused ring system selected from the group consisting of a furan, a thiophene, a pyridazine, a pyrazine, and a pyrimidine; A is selected from the group consisting of aryl, hydrogen, hydroxyl, alkoxy hydroxyalkyl, and a C 1 -C 4 straight chain or branched alkyl; Q is an aldehyde (alkene) or protected aldehyde; L is a linker selected from a C 1 -C 12 alkyl, aralkyl, and aryl, any of which is optionally substituted; wherein one or more methylene unit (CH 2 ) of said C 1 -C 12 alkyl is optionally replaced by any combination of oxygen, carbonyl (C═O), and NH; and Nu is a nucleic acid; with a support material displaying an amino or masked amino functional group. 19. The method of claim 18 , wherein A is hydrogen or methyl, Q is a protected aldehyde, Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-linked nucleic acid, and a 3′-phosphate linked modified nucleic acid. 20. The method of claim 18 , wherein A is hydrogen or methyl, Q is a protected aldehyde, Nu is selected from the group consisting of a 5′-phosphate-linked nucleic acid, a 5′-thiophosphate-linked nucleic acid, and a 5′-phosphate linked modified nucleic acid. 21. The method of claim 18 , wherein A is hydroxyl, alkoxy, or hydroxyalkyl, Q is a protected aldehyde, and Nu is selected from the group consisting of a 3′-phosphate-linked nucleic acid, a 3′-thiophosphate-lin

Assignees

Inventors

Classifications

  • Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids · CPC title

  • having the nitrogen atoms in the positions 1 and 2 · CPC title

  • having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate · CPC title

  • having the nitrogen atoms in positions 1 and 3 · CPC title

  • C07F9/5728Primary

    condensed with carbocyclic rings or carbocyclic ring systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9475831B2 cover?
A compound has Formula I: A, B, C, D, W, X, Y, and Z are independently selected from hydrogen, optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 6 alkoxy, aryl, aldehyde, protected aldehyde, CH, N, O, S, null, and bond; Q is selected from aldehyde, protected aldehyde, and null, at least one of A, B, C, D, W, X, Y, Z, or Q is an aldehyde or protect…
Who is the assignee on this patent?
Illumina Inc
What technology area does this patent fall under?
Primary CPC classification C07F9/5728. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).